Ruby Biopharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Ruby Biopharma Private Limited

Ruby Biopharma Private Limited, a active private limited company, was established on 21 January 2008 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234MH2008PTC178070. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Employing 3 professional, Its leadership includes Rumy Ravi Kumar (Director), Ruby Ravi Kumar (Director). Past directors included Prabha Ravi Kumar. It holds ₹25.40 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 11A Sandeep Park Deonar, Mumbai, Maharashtra, 400088.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24234MH2008PTC178070

  • Registration Number

    178070

  • Incorporation Date

    21 January 2008

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 18 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 25.40 Cr
  • Revenue Growth **** 2.26%
  • Profit Growth **** 74.06%
  • Ebitda **** 67.38%
  • Net Worth 21.32%
  • Total Assets **** 14.88%
Company report

Ruby Biopharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ruby Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ruby Biopharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rumy Ravi Kumar Director 21 Jan 2008 Current
Ruby Ravi Kumar Director 21 Jan 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Apr 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ruby Biopharma.

Ruby Biopharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.26% increase. The company also saw a substantial improvement in profitability, with a 74.06% increase in profit. The company's net worth Soared by an impressive increase of 21.32%.

Ruby Biopharma revenue growth over time
Ruby Biopharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.26%
*******
*******
*******
*******
Revenue from Operations
*******
 1.99%
*******
*******
*******
*******
Total Assets
*******
 14.88%
*******
*******
*******
*******
Profit or Loss
*******
 74.06%
*******
*******
*******
*******
Net Worth
*******
 21.32%
*******
*******
*******
*******
EBITDA
*******
 67.38%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ruby Biopharma?

Unlock access to Ruby Biopharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹254,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 25.40 Cr
Latest Charge Details
Date Lender Amount Status
03 Dec 2024 Axis Bank Limited ₹14.00 Cr Open
21 Mar 2024 Axis Bank Limited ₹6.00 Cr Open
04 Mar 2024 Axis Bank Limited ₹5.40 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Ruby Biopharma?

Ruby Biopharma has a workforce of 3 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ruby Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruby Biopharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ruby Biopharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 140.00 M with Charge ID 101010079 was registered on 03 Dec 2024. was completed.

  • Annual General Meeting

    The activity Ruby Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Ruby Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 60.00 M with Charge ID 100894143 was registered on 21 Mar 2024. was documented.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 54.00 M with Charge ID 100886643 was registered on 04 Mar 2024. was documented.

  • Director Appointment

    Rumy Ravi Kumar was appointed as a Director was appointed as a Director on 21 Jan 2008 & has been associated with this company since 18 years 2 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ruby Biopharma Private Limited?

The CIN of Ruby Biopharma Private Limited is U24234MH2008PTC178070.

Where is Ruby Biopharma Private Limited headquartered?

Ruby Biopharma Private Limited is headquartered at 11A Sandeep Park Deonar, Mumbai, Maharashtra, 400088.

When was Ruby Biopharma Private Limited incorporated?

Ruby Biopharma Private Limited was incorporated on 21 January 2008.

Who are the current directors of Ruby Biopharma Private Limited?

The current directors of Ruby Biopharma Private Limited are

What is the primary industry of Ruby Biopharma Private Limited?

The primary industry of Ruby Biopharma Private Limited is Manufacturing.

Is Ruby Biopharma Private Limited a listed company?

Ruby Biopharma Private Limited is unlisted.

What is the capital structure of Ruby Biopharma Private Limited?

The authorized capital of Ruby Biopharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of Ruby Biopharma Private Limited?

The compliance status of Ruby Biopharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available